🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨🚨 The WashU Epigenome Browser team is pleased to release the complete genome of the #coronavirus and introduce the #WashUVirusBrowser built on the intuitive WashU Epigenome Browser platform: virusgateway.wustl.edu (1/2)

Excited to see our study out: 🧬Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements!! nature.com/articles/s4158…. joshhjang Yonghao Liang Ting Wang Ju-Heon Maeng A thread highlighting the results 🧵 1/17

My first first-authored paper about "Finding transposable element (TE)-antigens using long reads" is published in Genome Research. Thank you to my mentor, Dr. Ting Wang. Please take a look if you're interested in TE expression and their antigens. genome.cshlp.org/content/early/…

Genomic dark matters are important for understanding and treating cancer. Joint work with Yonghao Liang , Xuan Qu and Nakul Shah.

🧬🚨 Our study on novel antigens induced in glioblastoma upon treatment with epigenetic therapy is out!! This study was led by joshhjang with co-first-authors Yonghao Liang and Ju-Heon Maeng, and mentored by Ting Wang and Albert H. Kim. 5 Key Takeaways: 1/5 nature.com/articles/s4158…

My last PhD project on epigenetic-treatment-induced novel antigens in glioblastoma is out. It was a privilege to work with the co-first authors, joshhjang, Nakul Shah, and Yonghao Liang, and mentors, Albert H. Kim and Ting Wang. Please read for more: nature.com/articles/s4158….

WashU Medicine researchers have found a way to make aggressive glioblastoma cells vulnerable to immunotherapy. Demonstrated in cells in the lab, researchers forced cancerous cells to display targets for the immune system to attack. medicine.washu.edu/news/researche…